Raymond James Initiates Coverage On Arch Biopartners with Market Perform Rating, Announces Price Target of C$3.5
Raymond James analyst Rahul Sarugaser initiates coverage on Arch Biopartners (TSXV:ARCH) with a Market Perform rating and announces Price Target of C$3.5.